Inogen Inc (INGN) Financial Statements
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
In fiscal 2025, Inogen reported revenue of $348.7M, up 3.9% from $335.7M the year before. Net income was -$22.7M (a -6.5% net margin), or -$0.86 per diluted share. Gross margin was 44.2% and operating margin was -8.7%. Operating activities generated -$11.2M of cash, leaving -$13.7M of free cash flow. At fiscal year end, Inogen held $298.6M in total assets against $106.4M in total liabilities, including $103.7M of cash and equivalents.
Open the full interactive Inogen financials → Quarterly statements, key ratios, valuation history and price charts.
Inogen Key Stats
| Share Price | $6.34 |
|---|---|
| Market Cap | $171.5M |
| Revenue YoY Growth | +3.9% |
| 52-Week Range | $5.09 – $8.95 |
| Shares Outstanding | 27.0 million (basic, 2026 Q2) |
Inogen Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $308.5M | $358.0M | $377.2M | $315.7M | $335.7M | $348.7M |
| Cost of Goods Sold | $156.8M | $161.8M | $197.8M | $158.6M | $148.7M | $163.8M |
| Gross Profit | $138.2M | $176.5M | $153.5M | $126.7M | $154.7M | $154.3M |
| Operating Income | -$12.0M | $9.2M | -$85.2M | -$109.4M | -$42.5M | -$30.2M |
| Pre-Tax Income | -$5.3M | $8.7M | -$83.3M | -$102.3M | -$36.5M | -$23.4M |
| Income Tax | $549,000 | $15.0M | $504,000 | $105,000 | -$588,000 | -$632,000 |
| Net Income | -$5.8M | -$6.3M | -$83.8M | -$102.4M | -$35.9M | -$22.7M |
| Diluted EPS | -$0.27 | -$0.28 | -$3.67 | -$4.42 | -$1.52 | -$0.86 |
Inogen Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $92.4M | $81.7M | $85.1M | $95.1M |
| Net Income | -$5.3M | -$7.1M | -$8.3M | -$3.9M |
| Diluted EPS | -$0.20 | -$0.27 | -$0.30 | -$0.14 |
Inogen Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $212.0M | $235.5M | $187.0M | $125.5M | $113.8M | $103.7M |
| Current Assets | $305.7M | $329.2M | $304.6M | $207.1M | $185.5M | $198.3M |
| Total Assets | $461.9M | $489.5M | $405.0M | $326.2M | $296.2M | $298.6M |
| Current Liabilities | $56.7M | $61.5M | $65.3M | $72.5M | $76.7M | $63.5M |
| Total Liabilities | $112.2M | $119.3M | $107.6M | $121.4M | $122.3M | $106.4M |
| Shareholders' Equity | $349.6M | $370.2M | $297.4M | $204.8M | $173.9M | $192.2M |
Inogen Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $37.0M | $23.6M | -$37.5M | -$3.2M | $5.9M | -$11.2M |
| Cash From Investing | -$25.6M | -$14.6M | -$10.9M | -$59.3M | -$14.0M | -$26.2M |
| Cash From Financing | $2.1M | $15.0M | $380,000 | $960,000 | $265,000 | $24.2M |
| Free Cash Flow | $32.6M | $18.2M | -$40.9M | -$8.5M | $2.6M | -$13.7M |
Figures from Inogen's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Inogen financials page for every line item.
Inogen Company Profile
| Ticker | INGN |
|---|---|
| Exchange | Nasdaq |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Headquarters | Beverly, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer, smaller reporting company |
| SEC CIK | 0001294133 |
Frequently Asked Questions
What was Inogen's revenue in fiscal 2025?
Inogen (INGN) reported revenue of $348.7M for fiscal 2025.
What is Inogen's annual revenue history?
Inogen's annual revenue by fiscal year: 2020: $308.5M; 2021: $358.0M; 2022: $377.2M; 2023: $315.7M; 2024: $335.7M; 2025: $348.7M.
What was Inogen's net income in fiscal 2025?
Inogen reported net income of -$22.7M for fiscal 2025.
What was Inogen's earnings per share (EPS) in fiscal 2025?
Inogen's diluted EPS was -$0.86 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Inogen generate in fiscal 2025?
Inogen generated -$13.7M of free cash flow in fiscal 2025.
What was Inogen's revenue last quarter?
In its most recent reported quarter (2026 Q2), Inogen reported revenue of $95.1M.
How many shares of Inogen are outstanding?
Inogen reported a weighted average of 27.0 million basic shares outstanding in 2026 Q2.
What is Inogen's market cap?
Based on its latest closing price, Inogen (INGN) has a market capitalization of about $171.5M.
When does Inogen's fiscal year end?
Inogen's fiscal year end, as registered with the SEC, is December 31.
Where is Inogen headquartered?
Inogen lists its business address in Beverly, Massachusetts in its SEC filings.
Inogen Competitors & Similar Companies
See all 20 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies →